8 Enzyme Engineering and Technology 219Ozturk DH, Erickson-Viitanen S. 1998. Expression and
purification of HIV-I p15NC protein in Escherichia
coli. Protein Expr Purif 14:54–64.
Panda AK. 2003. Bioprocessing of therapeutic proteins
from the inclusion bodies of Escherichia coli. Adv
Biochem Eng Biotechnol 85:43–93.
Panke S, Wubbolts MG. 2002. Enzyme technology and
bioprocess engineering. Curr Opin Biotechnol 13:
111–116.
Phadke RS. 1992. Biosensors and enzyme immobilized
electrodes. Biosystems 27:203–206.
Piefer AJ, Jonsson CB. 2002. A comparative study of
the human T-cell leukemia virus type 2 integrase
expressed in and purified from Escherichia coliand
Pichia pastoris. Protein Expr Purif 25:291–299.
Platis D, Foster GR. 2003. High yield expression,
refolding, and characterization of recombinant inter-
feron alpha2/alpha8 hybrids in Escherichia coli.
Protein Expr Purif 31:222–230.
Podgornik A, Tennikova TB. 2002. Chromatographic
reactors based on biological activity. Adv. Biochem
Eng Biotechnol 76:165–210.
Powell LW. 1984. Developments in immobilized-
enzyme technology. Biotechnol Genet Eng Rev 2:
409–438.
Price N, Stevens L. 1999. Fundamentals of Enzymol-
ogy, 3rd edition. Oxford University Press. Pp. 79–92.
Prunkard D., Cottingham I, Garner I, Bruce S,
Dalrymple M, Lasser G, Bishop P, Foster D. 1996.
High-level expression of recombinant human fib-
rinogen in the milk of transgenic mice. Nat Bio-
technol 14:867–871.
Regnier FE. 1987. Chromatography of complex protein
mixtures. J Chromatogr 418:115–143.
Richardson JS. 1981. The anatomy and taxonomy of
protein structure. Adv Protein Chem 34:167–339.
Roy P, Bishop DH, LeBlois H, Erasmus BJ. 1994.
Long-lasting protection of sheep against bluetongue
challenge after vaccination with virus-like particles:
Evidence for homologous and partial heterologous
protection. Vaccine 12:805–811.
Rudolph NS. 1999. Biopharmaceutical production in
transgenic livestock. Trends Biotechnol 17:367–374.
Russell DA. 1999. Feasibility of antibody production in
plants for human therapeutic use. Curr Top Micro-
biol Immunol 240:119–138.
Ryu DD, Nam DH. 2000. Recent progress in biomole-
cular engineering. Biotechnol Prog 16:2–16.
Sala F, Manuela RM, Barbante A, Basso B, Walmsley
AM, Castiglione S. 2003. Vaccine antigen produc-
tion in transgenic plants: strategies, gene constructs
and perspectives. Vaccine 21:803–808.
Schatz SM, Kerschbaumer RJ, Gerstenbauer G, Kral
M, Dorner F, Scheiflinger F. 2003. Higher expres-
sion of Fab antibody fragments in a CHO cell line at
reduced temperature. Biotechnol Bioeng 84:433–
438.
Schena M, Heller RA, Theriault TP, Konrad K,
Lachenmeier E, Davis RW. 1998. Microarrays: Bio-
technology’s discovery platform for functional geno-
mics. Trends Biotechnol 16:301–306.
Schena M, Shalon D, Davis RW, Brown PO. 1995.
Quantitative monitoring of gene expression patterns
with a complementary DNA microarray. Science
270:467–470.
Schillberg S, Fischer R, Emans N. 2003a. ‘Molecular
farming’ of antibodies in plants. Naturwissen-
schaften 90:145–155.
———. 2003b. Molecular farming of recombinant
antibodies in plants. Cell Mol Life Sci 60:433–445.
Schmidt-Dannert C, Umeno D, Arnold FH. 2000. Mol-
ecular breeding of carotenoid biosynthetic pathways.
Nat Biotechnol 18:750–753.
Schwede T, Kopp J, Guex N, Peitsch MC. 2003.
SWISS-MODEL: An automated protein homology-
modeling server. Nucleic Acids Res 31:3381–
3385.
Scopes RK. 1987. Dye-ligands and multifunctional
adsorbents: An empirical approach to affinity chro-
matography. Anal Biochem 165:235–246.
Scrutton NS, Berry A, Perham RN. 1990. Redesign of
the coenzyme specificity of a dehydrogenase by pro-
tein engineering. Nature 343:38–43.
Sgaramella V, Eridani S. 2004. From natural to artifi-
cial chromosomes: An overview. Methods Mol Biol
240:1–12.
Shao Z, Zhao H, Giver L, Arnold FH. 1998. Random-
priming in vitro recombination: An effective tool for
directed evolution. Nucleic Acids Res 26:681–683.
Sibanda BL, Blundel TL, Thornton JM. 1989. Con-
formation of beta-hairpins in protein structures. A
systematic classification with applications to model-
ling by homology, electron density fitting and pro-
tein engineering. J Mol Biol 206:759–777.
Singh A, Hayashi K, Hoa TT, Kashiwagi Y, Tokuyasu
K. 1995. Construction and characterization of a chim-
eric beta-glucosidase Biochem J 305 (Pt 3):715–
719.
Slade MB, Emslie KR, Williams KL. 1997. Expression
of recombinant glycoproteins in the simple eukary-
ote Dictyostelium discoideum.Biotechnol. Genet
Eng Rev 14:1–35.
Steine S, Anderson NL. 2000. Pharmaceutical pro-
teomics. Ann NY Acad Sci 919:48–51.